Benefit and Tolerability of IQP-LU-104 in Weight Loss

NCT03888911 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DIETARY_SUPPLEMENT: High dose IQP-LU-104 (5120mg)
DIETARY_SUPPLEMENT: Low dose IQP-LU-104 (2560mg)
DIETARY_SUPPLEMENT: Placebo

Sponsor

InQpharm Group